Oncrasin 1

CAS No. 75629-57-1

Oncrasin 1( —— )

Catalog No. M21162 CAS No. 75629-57-1

Oncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 37 Get Quote
5MG 59 Get Quote
10MG 95 Get Quote
25MG 206 Get Quote
50MG 374 Get Quote
100MG 545 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Oncrasin 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Oncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.
  • Description
    Oncrasin 1 is a potent inhibitor of anticancer that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    K-Ras
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    75629-57-1
  • Formula Weight
    269.73
  • Molecular Formula
    C16H12ClNO
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:43 mg/mL (159.42 mM)
  • SMILES
    O=Cc1cn(Cc2ccc(Cl)cc2)c2ccccc12
  • Chemical Name
    1-(4-Chlorobenzyl)-1H-indole-3-carbaldehyde

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Guo W Wu S Liu J et al. Identification of a Small Molecule with Synthetic Lethality for K-Ras and Protein Kinase C Iota[J]. Cancer Research 2008 68(18):7403-7408.
molnova catalog
related products
  • KRAS-G12C inhibitor ...

    KRAS-G12C inhibitor 13 is a potnt, irreversible, covalent and in vivo-active inhibitor of KRAS-G12C.

  • ADT-007

    ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.

  • KRAS inhibitor Cmpd2

    KRAS inhibitor Cmpd2 is a small-molecule compound that blocks biochemical and cellular functions of KRASG12V with IC50 of 0.8 uM in vitro.